Assistant Professor, Ophthalmology, Ohio State University College of Medicine
Ophthalmology
Dr. Colleen M. Cebulla, MD
|
|
Give Review
Colleen M. Cebulla, MD works in the field of Ophthalmology. She went to medical school at The Ohio State University College of Medicine. She over the years received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Dr. Colleen M. Cebulla is a published MD as well. She has 48 publications published. The latest was: Multimodal Imaging and Clinicopathologic Correlation in Primary Uveal Lymphoma. Colleen Cebulla accepts Medicare.
Publications
- A chick model of retinal detachment: cone rich and novel.
- Spectral domain Optical coherence tomography in a murine retinal detachment model.
- Activation of glucocorticoid receptors in Müller glia is protective to retinal neurons and suppresses microglial reactivity.
- Long-term visual acuity outcomes in patients with uveal melanoma treated with (125)I episcleral OSU-Nag plaque brachytherapy.
- Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.
- Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
- Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
- Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens.
- Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
- Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 Expression In Murine Experimental Retinal Detachment.
- Screening and characterization of Staphylococcus aureus from ophthalmology clinic surfaces: a proposed surveillance tool.
- Charles Bonnet syndrome and Terson's syndrome: good news from bad news.
- Calcification of combined hamartoma of the retina and retinal pigment epithelium over 15 years.
- Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous Hemorrhage from proliferative diabetic retinopathy.
- Atypical cat scratch disease with vitritis, serous Macular detachment, neuroretinitis, and retrobulbar optic neuritis.
- Charles Bonnet syndrome and Terson's syndrome from subarachnoid Hemorrhage: good news from bad news.
- Optic disc edema from remote uveal melanoma.
- Systemic treatment of vitreous inflammation.
- Intravitreal devices for the treatment of vitreous inflammation.
- Long-term survivors with metastatic uveal melanoma.
- Rapid formation and resolution of Cataracts following orthopedic surgery for a patient with Charcot-Marie-Tooth disease.
- RAPID APPEARANCE OF RHABDOMYOSARCOMA AFTER RADIATION AND CHEMOTHERAPY FOR RETINOBLASTOMA: A CLINICOPATHOLOGIC CORRELATION.
- Toward failure analyses in systems biology.
- Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.
- Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.
- Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma.
- Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
- Management of fluocinolone implant dissociation during implant exchange.
- Endophthalmitis after open Globe injuries.
- Basic fibroblast growth factor impact on retinoblastoma progression and survival.
- Tumor volume reduction using combined phacoemulsification and intravitreal triamcinolone injection for the management of Cataract with treated uveal melanoma and atypi...
- Targeting hypoxia, a novel treatment for advanced retinoblastoma.
- Human cytomegalovirus disrupts constitutive MHC class II expression.
- Multimodal Imaging and Clinicopathologic Correlation in Primary Uveal Lymphoma.
- A case of vogt-koyanagi-harada syndrome with persistent dyspnea secondary to laryngeal Edema.
- Lack of Effect of SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor-2, in a Transgenic Murine Model of Retinoblastoma.
- Cytomegalovirus and transcriptional down-regulation of major histocompatibility complex class II expression.
- Cytomegalovirus induces sialyl Lewis(x) and Lewis(x) on human endothelial cells.
- Viral inhibition of interferon signal transduction.
- Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction.
- Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retino...
- Diagnostic challenges in retinitis pigmentosa: genotypic multiplicity and phenotypic variability.
- Retinal tumor imaging and volume quantification in mouse model using spectral-domain Optical coherence tomography.
- Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy.
- Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
- Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression.
- Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature.
Schools
Ohio State University College Of Medicine and Public Health
Procedures Preformed
- Anterior Vitrectomy
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Enucleation of Eye
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Anisocoria
- Anterior Ischemic Optic Neuropathy
- Benign Neoplasm of Choroid
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Jackson Memorial Hospital - Jackson Health System -
Riverside Methodist Hospitals - OhioHealth -
The Ohio State University College of Medicine
Hospital
-
Ohio State University Wexner Medical Center -
Nationwide Children's Hospital
Drug Facts
| NPI NUMBER | 1144264334 | |
| NPPES Provider LastName | CEBULLA | |
| NPPES Provider FirstName | COLLEEN | |
| NPPES Provider ZIPCode | 432123153 | |
| NPPES Provider State | OH | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 75.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144264334 |
| Last Name Of The Provider | CEBULLA |
| First Name Of The Provider | COLLEEN |
| View All |
Similar Doctors
|
Dr. Thomas J. Dingle, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Frederick M. Kapetansky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack Dingle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Lehmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elson L. Craig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan J. Rehmar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Reiss, MD |
|
|
Dr. Ellen R. Miller, MD |